Abstract
The Dutch nationwide newborn screening (NBS) programme screens for 28 disorders using biomarkers measured in heel prick samples, preferably collected between the third and seventh day of life. This study aimed to assess the association of gestational age (GA), birth weight (BW), and age at heel prick with biomarker values within the Dutch NBS programme. Retrospective analysis of 1,479,708 screening results (2010–2020) for 20 biomarkers was performed. Statistical analyses consisted of multivariable linear analyses, ANOVA, and Scheffé’s post hoc test. Multivariable linear analyses showed moderate to strong associations of adult and foetal haemoglobin (HbA and HbF), 17-hydroxyprogesterone (17-OHP), and thyroxine (T4) with GA, BW, and/or age at heel prick (R ≥ 0.30). HbA and HbF were similarly influenced by both GA and age at heel prick, whereas 17-OHP and T4 were predominantly affected by GA. BW contributed minimally beyond GA, likely due to their biological correlation. For the other biomarkers, a less pronounced association was found. The findings indicate that current cut-off values for HbA, haemoglobin Bart’s 17-OHP, and T4 in the Dutch NBS programme may require re-evaluation, particularly for extremely premature newborns and for samples taken outside the preferred age window. Incorporating these findings, in combination with studies that include clinical outcomes, might improve the accuracy and predictive value of future NBS programmes.